Bladder Cancer - Results from #640

REVIEW UroToday

Current Landscape of Immune Checkpoint Inhibitors for Metastatic Urothelial Carcinoma: Is There a Role for Additional T-Cell Blockade? January 15, 2024

Clinical Outcomes in Response to Perioperative Chemotherapy in Bladder Cancer - Expert Commentary January 12, 2024

MRI/RNA-Seq-Based Radiogenomics and Artificial Intelligence for More Accurate Staging of Muscle-Invasive Bladder Cancer. January 12, 2024

Comprehensive Evaluation of the Ability of Comorbidity and Health Status Indices to Improve the Prediction of Perioperative Morbidity and Long-Term Survival Outcomes After Radical Cystectomy. January 12, 2024

The Financial Burden of Guideline-recommended Cancer Medications for Metastatic Urothelial Carcinoma. January 12, 2024

Systemic anticancer therapy for urothelial carcinoma: UK oncologists' perspective. January 11, 2024

Associations of TACSTD2/TROP2 and NECTIN-4/NECTIN-4 with molecular subtypes, PD-L1 expression, and FGFR3 mutational status in two advanced urothelial bladder cancer cohorts. January 11, 2024

Neoadjuvant Chemotherapy for Neuroendocrine Carcinoma of the Urinary Tract - Expert Commentary January 10, 2024

Comparative Effectiveness Analysis of Treatment Strategies for Surgically Resectable Neuroendocrine Carcinoma of the Urinary Tract. January 10, 2024

Stool Microbiome Signature Associated with Response to Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Cancer. January 10, 2024

Circulating Basophils as a Prognostic Marker for Response to Bacillus Calmette-Guérin. January 10, 2024

CREST: phase III study of sasanlimab and Bacillus Calmette-Guérin for patients with Bacillus Calmette-Guérin-naïve high-risk non-muscle-invasive bladder cancer. January 9, 2024

Comparative Effectiveness of Neoadjuvant Pembrolizumab Versus Cisplatin-based Chemotherapy or Upfront Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder Cancer. January 9, 2024

Longitudinal Analysis of Bladder Cancer-Specific Mortality Trends in the United States. January 8, 2024

Wake-Up Call to Address Sleep Health in Non-Muscle Invasive Bladder Cancer: Underappreciated Contributor to Poor Quality of Life. January 8, 2024

Exploring Pembrolizumab-Induced Myocarditis, Myositis, and Myasthenia Gravis: A Comprehensive Literature Review and Case Presentation on Bladder Cancer. January 5, 2024

Improved bladder cancer antitumor efficacy with a recombinant BCG that releases a STING agonist. January 5, 2024

The Long-Term Impact of 5-alpha Reductase Inhibitors on the Development of Bladder Cancer and the Need for Radical Cystectomy: A Nationwide Observational Study. January 4, 2024

Patterns of chemotherapy use in muscle-invasive bladder cancer in a tertiary centre. January 4, 2024

Patient reported treatment burden and attitudes towards in-home intravesical therapy among patients with bladder cancer. January 4, 2024

Page 33 of 517